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Abstract. This study was designed to examine stool specimens of irritable bowel syndrome (IBS) patients for
Blastocystis hominis, a common intestinal parasite. One hundred fifty patients were enrolled, 95 IBS cases and 55
controls. These patients provided a medical history, and underwent physical and laboratory evaluations that included
stool microscopy and culture for B. hominis and colonoscopy. The 95 cases (51 males and 44 females) had a mean ± SD
age of 37.8 ± 13.2 years. Stool microscopy was positive for B. hominis in 32% (30 of 95) of the cases and 7% (4 of 55)
of the controls (P  0.001). Stool culture was positive in 46% (44 of 95) of the cases and 7% (4 of 55) of the controls
(P < 0.001). Stool culture for B. hominis in IBS was more sensitive than microscopy (P < 0.001). Blastocystis hominis was
frequently demonstrated in the stool samples of IBS patients; however, its significance in IBS still needs to be investi-
gated. Stool culture has a higher positive yield for B. hominis than stool microscopy.
INTRODUCTION
Blastocystis hominis (B. hominis) is a unicellular protozoan
found in the large intestine of humans. Infection occurs
worldwide but is commonly found in the tropics and devel-
oping countries. The pathogenic potential of B. hominis in the
human intestine is controversial because the organism has
been found in both symptomatic and asymptomatic individu-
als. The morphologic forms observed include vacuolar, granu-
lar, and amoeboid.1 The morphologic form responsible for
transmitting the disease has not been identified, and spread is
presumed to be via the feco-oral route. The vacuolated form
is most commonly found in feces.2 Infection is usually diag-
nosed on the basis of direct microscopy of the fecal sample
and observing the vacuolated form of the organism using a
light microscope. Cultures of B. hominis, although easy to
prepare, are not done routinely, although a previous study
demonstrated that cultures of B. hominis were clearly supe-
rior to direct microscopy in terms of sensitivity.3 Superficial
invasion and mucosal inflammation of the intestine with B.
hominis have been observed in studies of gnotobiotic guinea
pigs.4 Although controlled studies of the association between
B. hominis and diarrhea are lacking, there have been studies
that have examined the link between B. hominis and irritable
bowel syndrome (IBS).5,6 Levels of IgG antibody to B. homi-
nis were increased significantly in the patients with IBS com-
pared with asymptomatic controls.5 This is suggestive of a link
between B. hominis and IBS. The aim of this study was to
determine the prevalence of B. hominis in patients with symp-
toms suggestive of IBS.
PATIENTS AND METHODS
This prospective study was conducted at the Aga Khan
University Hospital in Karachi, Pakistan. Ninety-five patients
with symptoms suggestive of IBS, according to the Rome II
criteria, who attended the gastroenterology clinic from Janu-
ary 2002 to June 2003 were recruited into the study. The
Rome II criteria is at least 12 weeks or more, which need not
be consecutive, in the preceding 12 months of abdominal dis-
comfort or pain that has two of three features: relieved with
defecation; and/or onset associated with a change in fre-
quency of stool; and/or onset associated with a change in form
of stool.7 Patients in the IBS group presented with abdominal
pain or discomfort associated with altered bowel habits. In
control group, there was a recent onset of diarrhea, loss of
appetite, fever, and abdominal discomfort. These patients
provided a thorough medical history and underwent a physi-
cal examination, and the following tests were conducted: com-
plete blood count, erythrocyte sedimentation rate, liver func-
tion, blood urea nitrogen, creatinine, electrolytes, stool mi-
croscopy and culture for B. hominis. Colonoscopy with biopsy
was carried out in each of the patients who fulfilled the cri-
teria for IBS. Informed consent was obtained for colonoscopy
in all the patients as per Aga Khan University Hospital policy.
The study was reviewed and approved by ethics review com-
mittee of the Department of Medicine of Aga Khan Univer-
sity. Technologists were unaware of the classification status of
the patients. All stool specimens for microscopy and culture
of B. hominis were processed by the same technicians and a
note was also made of presence of other parasites such as
Giardia lamblia, Entamoeba histolytica, etc. A microbiologic
investigation was also performed to detect Salmonella spp,
Campylobacter jejuni, Clostridium difficile, and Vibrio cho-
lera. A viral screen was not performed on stool specimens
obtained in view of cost limitations.
Microscopy of fecal smears. Fecal sample microscopy was
done as previously described.3 Briefly, approximately 2 mg of
feces was thoroughly emulsified on a glass slide in one drop of
physiologic saline and covered with a cover slip. A similar
preparation was made on another slide using Lugol’s iodine.
These preparations were examined under both the low power
(10×) and high dry (40×) objectives.
Culture of feces. Cultures were done by inoculating ap-
proximately 50 mg of feces into Jones’ medium. For culturing
B. hominis, Jones medium without starch was used because it
supports good growth of the parasite as previously described.3
The cultures were incubated at 37°C and examined after 24,
48, 72, and 96 hours. If no B. hominis were seen up to the end
of this period, the cultures were regarded as negative. The
sediment was examined under both the low power (10×) and
high dry (40×) objectives.
Statistical analysis. Results are expressed as the mean ± SD
for continuous variables (e.g, age) and number (percentage)
for categorical data (e.g, sex, stool culture, diarrhea, etc.).
Univariate analysis was performed using the independent
sample t-test. The Pearson chi-square test and Fisher’s exact
Am. J. Trop. Med. Hyg., 70(4), 2004, pp. 383–385
Copyright © 2004 by The American Society of Tropical Medicine and Hygiene
383
test were also used whenever appropriate. A P value < 0.05
was considered statistically significant. All P values were two
sided. Statistical interpretation of data was performed by us-
ing the computerized software program SPSS version 10.0
(SPSS Inc., Chicago, IL).
RESULTS
Irritable bowel syndrome group. This group was composed
of 51 males and 44 females with a mean ± SD age of 37.7 ± 13
years. Symptoms were equally common in males and females.
Abdominal pain was seen in 80% (70 of 95) and was de-
scribed as cramping in 64% (45 of 70). The bowel habit was
described as diarrhea in 73% (69 of 95) and constipation in
13% (12 of 95). Consistency of stool varied from semi-formed
in 33% (31 of 95), normal 25% (24 of 95), and loose 42% (40
of 95). Clonoscopy showed patchy erythema in the rectum
and sigmoid colon in 11% (10 of 95) and 3% (3 of 95), re-
spectively. This was later confirmed to be nonspecific inflam-
mation.
Control group. This group was composed of 19 males and
36 females with a mean ± SD age of 44.6 ± 20.5 years. A vague
abdominal pain was present in only 40% (22 of 55). The
bowel habit was described as diarrhea in 87.3% (48 of 55)
with loose consistency of stools.
Comparison of the IBS and control groups. The IBS symp-
toms were equally common in males and females. Seventy-
four percent (70 of 95) of the cases and 40% (22 of 55) of the
controls had abdominal pain (P < 0.001). Seventy-three per-
cent (69 of 95) of the cases and 87% (48 of 55) of the controls
had a bowel habit described as diarrhea (P 0.042). In con-
trol group, 33% (18 of 55) presented with fever and 42% (23
of 55) with loss of appetite, while patients in IBS group did
not demonstrate these features.
Stool microscopy. Stool microscopy was positive for B.
hominis in 32% (30 of 95) of the IBS patients and in 7.3%
(4 of 55) of the control group. Two percent (2 of 95) of the
IBS patients were positive for cysts of Entamoeba coli.
Stool culture. Stool culture was positive for B. hominis in
46% (44 of 95) of the IBS patients and in 7.3% (4 of 55) of the
control group. The organisms isolated from stool microscopy
and culture in the control group is shown in Table 1.
Comparison of stool microscopy and culture. Stool micros-
copy in both groups of patients yielded positive results for
B. hominis in 23% (34 of 150) compared with 32% (48 of 150)
by stool culture. Stool culture for B. hominis was more sen-
sitive than microscopy (P < 0.001) (Table 2).
DISCUSSION
Blastocystis hominis is one of the most common intestinal
protozoa in humans.6 It appears in both immunocompetent
and immunocompromised individuals.8,9 Although several re-
ports have suggested that B. hominis could cause gastrointes-
tinal disorders, the specific pathogenicity of this organism has
not yet been defined.10–13 The clinical consequences of B.
hominis infection are mainly diarrhea or abdominal pain with
nonspecific gastrointestinal symptoms such as nausea, an-
orexia, vomiting, weight loss, lassitude, dizziness, and flatu-
lence.2 It has been speculated that thick-walled cysts might be
responsible for external transmission, while thin-walled cysts
might reinfect within a host’s intestinal tract.11,12 The trans-
missible form of this organism has not yet been defined. It has
been suggested that B. hominis could be transmitted via un-
treated water.13,14 The various mechanisms suggested for B.
hominis-mediated gastrointestinal symptoms include adher-
ence of B. hominis to the gut epithelium, triggering a lysis
mechanism as shown for E. histolytica, G. lamblia, and exis-
tence of a diarrheagenic toxin present in culture filtrates and
in a B. hominis cell-free fraction.4,15–17
In this study, B. hominis was isolated from the feces of 46%
of the IBS patients. These patients came from different resi-
dential areas of the city and diverse walks of life; however, a
high prevalence of B. hominis would not reflect their personal
hygiene. Although few reports have found that B. hominis
was common in various age groups, our study failed to show
a significant association in any age group.10 Several reports
have suggested that the association of persistent bowel dys-
function is likely to be associated with deeper penetration of
the B. hominis and thus more severe mucosal inflamma-
tion.18,19 However, evidence of ulceration or invasion of B.
hominis into the tissue could not be found by colonoscopy
and biopsies in our patients with IBS. This might be consistent
with the results of Phillips and Zierdt, who showed that in-
vasion of B. hominis took place only under certain condition
in germ-free guinea pigs.20 Histopathologic examination of
rectal and sigmoid colonic tissues with non-specific inflamma-
tion failed to demonstrate B. hominis. This represents a mild
increase in inflammatory cells for which there may not be a
necessary and specific etiology, and may be part of the normal
variation in our population.
In IBS patients, cysts of Entamoeba coli were also demon-
strated on stool microscopy, which is associated with asymp-
tomatic carriage. Stool culture appeared to be more sensitive
in diagnosing B. hominis infection than microscopy (46% ver-
sus 32%), which is consistent with our previous study.3
This prevalence study shows an association between B.
hominis and IBS, although the study population was small. In
TABLE 1
Frequency of organisms isolated from the stool of patients in the
control group (n 55)
Bacteria
Vibrio cholera 16.3% (9)
Campylobacter jejuni 9% (5)
Salmonella typhi 5.4% (3)
Clostridium difficile 3.6% (2)
Parasites
Ascaris lumbricoides 9% (5)
Blastocystis hominis 7.3% (4)
Entamoeba histolytica 5.4% (3)
Giardia lamblia 2% (1)
Idiopathic 42% (23)
TABLE 2
Isolation of Blastocystis hominis by stool microscopy and culture in
the irritable bowel syndrome and control groups
Count
Stool microscopy
PNegative Positive
Stool culture
Positive 16 32 <0.001
Negative 100 2
Total 116 34
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some IBS patients, the presence of B. hominis may not be
casual and responsible for diarrhea. It has been previously
demonstrated that IBS patients had significantly high-levels
of specific IgG antibodies against B. hominis.5 Also, a sub-
group of IBS patients have persistently increased concentra-
tions of inflammatory cytokines that include interleukin-1,
which by inhibiting absorption of sodium and water, could
contribute to persistent diarrhea.21 In our study, a significant
proportion of IBS patients demonstrated B. hominis in their
fecal samples. However, in view of its pathogenic and non-
pathogenic strains, it requires further studies to confirm the
pathogenic role of B. hominis in IBS in a larger sample size.
Stool culture again has a higher yield for B. hominis than stool
microscopy.
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